Survival of Patents with Metastases from Uveal Melanoma

Ophthalmology

Volumn 98, Issue 3, 1991, Pages 383-390

  Gragoudas, Evangelos S ^a   Egan, Kathleen M ^a   Seddon, Johanna M ^a   Glynn, Robert J ^a   Walsh, Susan M ^a   Finn, Susan M ^a   Munzenrider, John E ^b   Spar, Myles D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FAST PROTON RADIATION; FEMALE; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE; UVEA MELANOMA;

EID: 0025962917     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(91)32285-1     Document Type: Article

References (38)

1. Choroidal melanoma: prognosis
2. Prognosis in metastatic choroidal melanoma
3. Survival in metastatic ocular melanoma
4. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge
5. Metastatic patterns of choroidal melanoma
6. Proton beam irradiation: an alternative to enucleation for intraocular melanomas
7. Nonparametric estimation from incomplete observations
8. Asymptotically efficient rank invariant test procedures
9. Regression models and life-tables
10. The PHGLM Procedure
11. Metastasis from uveal melanoma after proton beam irradiation
12. Malignant melanomas of the uvea in Denmark 1943-1952. A clinical, histopathological and prognostic study
13. Prolonged survival in a patient with hepatic malignant melanoma treated by intra-arterial bleomycin and oral hydroxyurea
14. Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma
15. ‘LFTs’ test more than the liver [editorial]
16. Detection of metastatic liver disease. Use of liver scans and biochemical liver tests
17. Metastatic uveal melanoma: pretherapy serum liver enzyme and liver scan Abnormalities
18. The incidence of metastases from untreated ciliary body and choroidal melanoma
19. Metastasis from untreated uveal melanomas
20. Metastatic choroidal melanoma
21. The cellular basis of site-specific tumor metastasis
22. Regional treatment of hepatic metastases and hepatocellular carcinoma
23. Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma
24. The systemic chemotherapy of hepatic metastases
25. Adjuvant therapy of cutaneous malignant melanoma: a critical review
26. Newer immunologic approaches to the treatment of patients with melanoma
27. Active-specific immunotherapy for melanoma
28. Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma
29. Therapy for cutaneous melanoma: an update
30. Clinical drug development: an analysis of phase II trials, 1970-1985
31. Significant survival benefit of node-negative breast cancer patients with adjuvant chemotherapy: seven-year results
32. Adjuvant therapy for patients with colon and rectal cancer
33. Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial
34. DTIC and combination therapy for melanoma. III. DTIC (NSC 45388) surgical adjuvant study COG PROTOCOL 7040
35. Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group Study
36. Adjuvant therapy of cutaneous malignant melanoma: a critical review
37. Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma